Page 1 of 1

Eli Lilly (LLY)

PostPosted: Tue Oct 20, 2015 7:22 am
by winston
not vested

Sell This Pharma Stock Before It Goes Limp

By Alan Gula

Source: Wall Street Daily

http://www.thetradingreport.com/2015/10 ... goes-limp/

Re: Eli Lilly (LLY)

PostPosted: Wed Mar 16, 2016 9:03 pm
by winston
Blue-chip drugmaker Eli Lilly falls to a 52-week low... down 17% over the past three months.

Re: Eli Lilly (LLY)

PostPosted: Wed Nov 23, 2016 9:17 pm
by winston
Eli Lilly shares tank after Alzheimer's drug fails in late-stage trial

by Matthew J. Belvedere

Incoming CEO David Ricks said Lilly stands by July projections, calling for revenues to grow an average of 5 percent between by the end of the decade, and calling for margins to improve without solanezumab.


Source: CNBC

http://www.cnbc.com/2016/11/23/eli-lill ... trial.html

Re: Eli Lilly (LLY)

PostPosted: Thu Jul 26, 2018 2:40 pm
by winston
not vested

A DRUG COMPANY BOUNCES BACK

Eli Lilly (LLY) is a $98 billion pharmaceutical giant. The company struggled earlier this year...

First, global competition hurt its animal health drug sales in the fourth quarter. Then, the market correction struck. LLY dropped more than 15% in just eight trading days. But the underlying business was still strong...

In the latest quarter, Eli Lilly reported sales of $6.36 billion, up 9% year over year. And it announced plans to spin off its lagging animal health unit.

As you can see in the chart below, shares are up more than 20% from their February lows, and they recently hit a new 52-week high.

When investors overreact, it can set up a rally as things simply get "less bad"...

Source: Daily Wealth

Re: Eli Lilly (LLY)

PostPosted: Wed Jul 31, 2019 6:17 pm
by winston
not vested

Eli Lilly & Co. (LLY)

Goldman's analysts see strong potential for its new products in the areas of diabetes, cancer, pain management, and immunology, and project that EPS will grow at a compound annual growth rate (CAGR) of 14.6% in the 2019 to 2022 time frame.

Source: Investopedia

Re: Eli Lilly (LLY)

PostPosted: Tue Apr 28, 2020 9:49 pm
by winston
not vested

CONSUMERS AREN'T JUST STOCKING UP ON GROCERIES

Today's stock is hitting new highs as people prepare for isolation...

With more than 300 million people under shelter-in-place orders in the U.S., consumers are stocking up on goods. They're making sure that they're prepared if the lockdowns get extended longer than expected. We've seen this trend in groceries and cleaning products. And the same goes for prescriptions...

Eli Lilly (LLY) is a $155 billion pharmaceutical giant. It makes important drugs like Trulicity and Humalog (diabetes treatments), Alimta (lung cancer treatment), and Taltz (autoimmune-disease vaccines).

The COVID-19 pandemic has accelerated sales of these lifesaving medicines... In its first-quarter earnings report, CEO David Ricks said the company was seeing higher patient and supply chain purchasing as people stock up on the drugs they need. That contributed to a 15% jump in revenue in the quarter.

As you can see in today's chart, LLY has surged higher recently. The stock is up more than 50% from its October lows, and it just hit a new all-time high. As people rush to make sure all their needs are covered, this stock should continue higher...

Source: Daily Wealth

Re: Eli Lilly (LLY)

PostPosted: Tue Jan 26, 2021 9:06 pm
by winston
THE BABY BOOMER GENERATION COULD BE A TAILWIND FOR THIS STOCK

Today, we're checking in on a company that benefits as the population ages...

Longtime readers know our colleague Dr. David Eifrig is bullish on the health care sector. As the Baby Boomer generation gets older and needs more medicines and treatments, health care stocks should see huge gains. Today's company is working hard to provide care for ailing seniors...

Eli Lilly (LLY) is a $200 billion pharmaceutical giant. It develops and produces a range of important medications, from diabetes treatments to cancer drugs. The company has also been working on a therapy to slow Alzheimer's disease...

In fact, its Alzheimer's drug donanemab recently saw positive results in Phase II clinical trials. With an estimated 5.8 million people suffering from Alzheimer's disease – 80% of those being 75 or older – the need to slow this disease is crucial.

As you can see, LLY shares have surged in recent months. The stock is up 75% from its March lows, and it just hit an all-time high. As long as Eli Lilly continues to provide essential treatments to American seniors, this stock should continue higher...

Source: Daily Wealth

Re: Eli Lilly (LLY)

PostPosted: Sun Nov 12, 2023 12:59 pm
by behappyalways
Lilly's New Weight Loss Medication Ignites Obesity Drug Price War
https://www.zerohedge.com/markets/lilly ... -price-war

Re: Eli Lilly (LLY)

PostPosted: Fri Mar 15, 2024 8:37 pm
by behappyalways
Weight-loss pills are out of stock! Drug manufacturer uses Oscar-winning ad to promote "Taking pills is not just to lose weight like a star"
減重藥缺貨! 藥廠搭奧斯卡熱推廣告「吃藥不是為了像明星一樣瘦」|方念華|FOCUS全球新聞 20240312 @tvbsfocus
https://m.youtube.com/watch?v=_y5PM-W1xvQ


Attention Obese Americans: You Can Now Order Eli Lilly's Weight Loss Drug On Amazon
https://www.zerohedge.com/medical/atten ... rug-amazon